Mizuho Markets Americas’s Haemonetics HAE Stock Holding History

Mizuho Markets Americas’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.2M	Buy	282,214 +89,900	+47%	+$5.77M	0.33%	65
2026 Q1	$10.8M	Sell	192,314 -86,000	-31%	-$5.6M	0.3%	69
2025 Q4	$22.3M	Buy	278,314 +146,000	+110%	+$9.81M	0.43%	61
2025 Q3	$6.45M	Sell	132,314 -103,700	-44%	-$6.42M	0.12%	85
2025 Q2	$17.6M	Sell	236,014 -33,248	-12%	-$2.2M	0.54%	42
2025 Q1	$17.1M	Sell	269,262 -83,716	-24%	-$5.69M	0.35%	56
2024 Q4	$27.6M	Buy	352,978 +4,500	+1%	+$361K	0.49%	47
2024 Q3	$28M	Sell	348,478 -15,116	-4%	-$1.22M	0.58%	34
2024 Q2	$30.1M	Buy	+363,594	New	+$32M	0.72%	24

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mizuho Markets Americas's HAE Position: Q2 2026 in Review

Mizuho Markets Americas increased its Haemonetics (HAE) stake by 47% in Q2 2026, buying an estimated $5.77M and bringing the position to 282,214 shares worth $21.2M. The position accounts for 0.33% of the portfolio, ranked #65.

Mizuho Markets Americas first reported a position in HAE in Q2 2024 and has held it in 9 quarters since. The position peaked at $30.1M in Q2 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Mizuho Markets Americas held 282,214 shares of Haemonetics worth $21.2M as of Q2 2026.
Mizuho Markets Americas bought 89,900 Haemonetics shares in Q2 2026, an estimated $5.77M.
Haemonetics made up 0.33% of Mizuho Markets Americas's portfolio in Q2 2026, its #65 holding.
Mizuho Markets Americas first reported a position in Haemonetics in Q2 2024 and has held it in 9 quarters since.
Mizuho Markets Americas's Haemonetics position peaked at $30.1M in Q2 2024.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Mizuho Markets Americas's 13F filing for Q2 2026, filed 24 Jul 2026.